Molecular basis of the obesity associated with Bardet-Biedl syndrome

Trends in Endocrinology and Metabolism

Volumn 22, Issue 7, 2011, Pages 286-293

  Guo, Deng Fu ^a   Rahmouni, Kamal ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BBS1 PROTEIN; BBS10 PROTEIN; BBS11 PROTEIN; BBS12 PROTEIN; BBS13 PROTEIN; BBS14 PROTEIN; BBS15 PROTEIN; BBS2 PROTEIN; BBS3 PROTEIN; BBS4 PROTEIN; BBS5 PROTEIN; BBS6 PROTEIN; BBS7 PROTEIN; BBS8 PROTEIN; BBS9 PROTEIN; CHAPERONIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LEPTIN; MELANIN CONCENTRATING HORMONE RECEPTOR 1; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE Y; PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BARDET BIEDL SYNDROME; BODY MASS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CILIARY MOTILITY; DISEASE ASSOCIATION; ENERGY EXPENDITURE; EUKARYOTIC FLAGELLUM; GENETICS; HUMAN; HYPERLEPTINEMIA; HYPOTHALAMUS FUNCTION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SINGLE NUCLEOTIDE POLYMORPHISM; UBIQUITINATION;

EID: 79959874896     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.02.009     Document Type: Review

References (86)

1. Bardet, G. (1920) Sur Un Syndrome D'obesité Infantile Avec Polydactylie et Rétinite Pigmentaire (Contribution à l'Étude des Formes Cliniques de l'Obesité Hypophysaire), Thesis 470, University of Paris.
2. Green J.S., et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N. Engl. J. Med. 1989, 321:1002-1009.
3. Harnett J.D., et al. The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N. Engl. J. Med. 1988, 319:615-618.
4. Elbedour K., et al. Cardiac abnormalities in the Bardet-Biedl syndrome: echocardiographic studies of 22 patients. Am. J. Med. Genet. 1994, 52:164-169.
5. Blacque O.E., Leroux M.R. Bardet-Biedl syndrome: an emerging pathomechanism of intracellular transport. Cell. Mol. Life Sci. 2006, 63:2145-2161.
6. Zaghloul N.A., Katsanis N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J. Clin. Invest. 2009, 119:428-437.
7. Leitch C.C., et al. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat. Genet. 2008, 40:443-448.
8. Dawe H.R., et al. The Meckel-Gruber Syndrome proteins MKS1 and meckelin interact and are required for primary cilium formation. Hum. Mol. Genet. 2007, 16:173-186.
9. Chang B., et al. In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse. Hum. Mol. Genet. 2006, 15:1847-1857.
10. Kim S.K., et al. Planar cell polarity acts through septins to control collective cell movement and ciliogenesis. Science 2010, 329:1337-1340.
11. Badano J.L., et al. Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Hum. Mol. Genet. 2003, 12:1651-1659.
12. Beales P.L., et al. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am. J. Hum. Genet. 2003, 72:1187-1199.
13. Katsanis N., et al. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 2001, 293:2256-2259.
14. Katsanis N. The oligogenic properties of Bardet-Biedl syndrome. Hum. Mol. Genet. 2004, 1:65-71.
15. Mykytyn K., et al. Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am. J. Hum. Genet. 2003, 72:429-437.
16. Fan Y., et al. Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat. Genet. 2004, 36:989-993.
17. Moore S.J., et al. Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am. J. Med. Genet. Part A 2005, 132A:352-360.
18. Sheffield V.C. Use of isolated populations in the study of a human obesity syndrome, the Bardet-Biedl syndrome. Pediatr. Res. 2004, 55:908-911.
19. Croft J.B., et al. Obesity in heterozygous carriers of the gene for the Bardet-Biedl syndrome. Am. J. Med. Genet. 1995, 55:12-15.
20. Benzinou M., et al. Bardet-Biedl syndrome gene variants are associated with both childhood and adult common obesity in French Caucasians. Diabetes 2006, 55:2876-2882.
21. Davenport J.R., Yoder B.K. An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am. J. Physiol. Renal Physiol. 2005, 289:F1159-F1169.
22. Singla V., Reiter J.F. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science 2006, 313:629-633.
23. Rosenbaum J.L., Witman G.B. Intraflagellar transport. Nat. Rev. Mol. Cell Biol. 2002, 3:813-825.
24. Mykytyn K., et al. Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:8664-8669.
25. Li J.B., et al. Comparative and basal genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 2004, 117:541-552.
26. Kim J.C., et al. The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression. Nat. Genet. 2004, 36:462-470.
27. Blacque O.E., et al. Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev. 2004, 18:1630-1642.
28. Yen H.J., et al. Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffer's vesicle cilia function. Hum. Mol. Genet. 2006, 15:667-677.
29. Tobin J.L., Beales P.L. Restoration of renal function in zebrafish models of ciliopathies. Pediatr. Nephrol. 2008, 23:2095-12095.
30. Nishimura D.Y., et al. Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16588-16593.
31. Mykytyn K., et al. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat. Genet. 2002, 31:435-438.
32. Davis R.E., et al. A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19422-19427.
33. Berbari N.F., et al. Bardet-Biedl syndrome proteins are required for the localization of G protein-coupled receptors to primary cilia. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:4242-4246.
34. Brailov I., et al. Localization of 5-HT6 receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res. 2000, 872:271-275.
35. Davenport J.R., et al. Disruption of intraflagellar transport in adult mice leads to transport obesity and slow-onset cystic kidney disease. Curr. Biol. 2007, 17:1586-1594.
36. Mak H.Y., et al. Polygenic control of Caenorhabditis elegans fat storage. Nat. Genet. 2006, 38:363-368.
37. Nachury M.V., et al. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 2007, 129:1201-1213.
38. Loktev A.V., et al. A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. Dev. Cell 2008, 15:854-865.
39. Seo S.J., et al. BBS6 BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2054-2059.
40. Chiang A.P., et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6287-6292.
41. Locke M., et al. TRIM32 is an E3 ubiquitin ligase for dysbindin. Hum. Mol. Genet. 2009, 18:2344-2358.
42. Grace C., et al. Energy metabolism in Bardet-Biedl syndrome. Int. J. Obes. 2003, 27:1319-1324.
43. Feuillan P.P., et al. Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance. J. Clin. Endocrinol. Metab. 2011, 96:E528-535.
44. Moore S.J., et al. Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am. J. Med. Genet. A 2005, 132:352-360.
45. Beales P.L. Lifting the lid on Pandora's box: the Bardet-Biedl syndrome. Curr. Opin. Genet. Dev. 2005, 15:315-323.
46. Willer C.J., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 41:25-34.
47. Zaghloul N.A., et al. Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:10602-10607.
48. Eichers E.R., et al. Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. Hum. Genet. 2006, 120:211-226.
49. Rahmouni K., et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J. Clin. Invest. 2008, 118:1458-1467.
50. Zhang Y., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
51. Morton G.J., et al. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
52. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004, 116:337-350.
53. Coll A.P., et al. The hormonal control of food intake. Cell 2007, 129:251-262.
54. Fath M.A., et al. Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome. Hum. Mol. Genet. 2005, 14:1109-1118.
55. Seo S.J., et al. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum. Mol. Genet. 2009, 18:1323-1331.
56. Banks W.A., et al. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
57. Chen H., et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495.
58. Iida M., et al. Substitution at codon 269 (glutamine -> proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 1996, 224:597-604.
59. Iida M., et al. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem. Biophys. Res. Commun. 1996, 222:19-26.
60. Lee G.H., et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996, 379:632-635.
61. Phillips M.S., et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 1996, 13:18-19.
62. Takaya K., et al. Molecular cloning of rat leptin receptor isoform complementary DNAs-identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem. Biophys. Res. Commun. 1996, 225:75-83.
63. Myers M.G., et al. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 2008, 70:537-556.
64. Bates S.H., et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003, 421:856-859.
65. Myers M.G., et al. The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab. 2009, 9:117-123.
66. Forti E., et al. Temporal expression pattern of Bardet-Biedl syndrome genes in adipogenesis. Int. J. Biochem. Cell Biol. 2007, 39:1055-1062.
67. Marion V., et al. Transient ciliogenesis involving Bardet-Biedl syndrome proteins is a fundamental characteristic of adipogenic differentiation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1820-1825.
68. Baly C., et al. Leptin and its receptors are present in the rat olfactory mucosa and modulated by the nutritional status. Brain Res. 2007, 1129:130-141.
69. Antal-Zimanyi I., Khawaja X. The role of melanin-concentrating hormone in energy homeostasis and mood disorders. J. Mol. Neurosci. 2009, 39:86-98.
70. Pissios P. Animals models of MCH function and what they can tell us about its role in energy balance. Peptides 2009, 30:2040-2044.
71. Frassetto A., et al. Reduced sensitivity to diet-induced obesity in mice carrying a mutant 5-HT6 receptor. Brain Res. 2008, 1236:140-144.
72. Badano J.L., et al. The ciliopathies: an emerging class of human genetic disorders. Annu. Rev. Genom. Hum. Genet. 2006, 7:125-148.
73. Saeki H., et al. Immotile cilia syndrome associated with polycystic kidney. J. Urol. 1984, 132:1165-1166.
74. Afzelius B.A. Human syndrome caused by immotile cilia. Science 1976, 193:317-319.
75. Nauli S.M., et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 2003, 33:129-137.
76. Yoder B.K., et al. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 2002, 13:2508-2516.
77. Afzelius B.A. Cilia-related diseases. J. Pathol. 2004, 204:470-477.
78. Tan S.Y., et al. Heterotaxy and complex structural heart defects in a mutant mouse model of primary ciliary dyskinesia. J. Clin. Invest. 2007, 117:3742-3752.
79. Hornef N., et al. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am. J. Respir. Crit. Care Med. 2006, 174:120-126.
80. Cardenas-Rodriguez M., Badano J.L. Ciliary biology: understanding the cellular and genetic basis of human cillopathies. Am. J. Med. Genet. Part C: Semin. Med. Genet. 2009, 151C:263-280.
81. Collin G.B., et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat. Genet. 2002, 31:74-78.
82. Hearn T., et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat. Genet. 2002, 31:79-83.
83. Slavotinek A.M., et al. Mutations in MKKS cause Bardet-Biedl syndrome. Nat. Genet. 2000, 26:15-16.
84. Collin G.B., et al. Alms1-disrupted mice recapitulate human Alström syndrome. Hum. Mol. Genet. 2005, 14:2323-2333.
85. Arsov T., et al. Fat Aussie-a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol. Endocrinol. 2006, 20:1610-1622.
86. Irani B.G., et al. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology 2007, 148:310-316.